Your search returned 25 results.

Results
	21.	Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. [electronic resource] by Zeng, Xiao-Hua Ou, Zhou-Luo Yu, Ke-Da Feng, Lan-Yun Yin, Wen-Jing Li, Jing Shen, Zhen-Zhou Shao, Zhi-Ming Producer: 20110502 In: Breast cancer research and treatment vol. 125 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells. [electronic resource] by Chen, Ying Chen, Li Li, Ji-Yu Mukaida, Naofumi Wang, Qiaoqiao Yang, Chen Yin, Wen-Jin Zeng, Xiao-Hua Jin, Wei Shao, Zhi-ming Producer: 20110914 In: Cancer biology & therapy vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway. [electronic resource] by Zhang, Hui Lang, Ting-Yuan Zou, Dong-Ling Zhou, Lei Lou, Meng Liu, Jing-Shu Li, Yun-Zhe Ding, Dong-Yan Li, Yu-Cong Zhang, Na Zheng, Xiao-Dong Zeng, Xiao-Hua Zhou, Qi Li, Li Publication details: OncoTargets and therapy 2019 In: OncoTargets and therapy vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	24.	Clinicopathologic Factors Related to the Histological Tumor Grade of Breast Cancer in Western China: An Epidemiological Multicenter Study of 8619 Female Patients. [electronic resource] by Zheng, Ke Tan, Jin-Xiang Li, Fan Li, Hong-Yuan Zeng, Xiao-Hua Ma, Bin-Lin Ou, Jiang-Hua Li, Hui Yang, Sui-Sheng Jiang, Ai-Mei Ni, Qing Liu, Jian-Lun Liu, Jin-Ping Zheng, Hong Ling, Rui He, Jian-Jun Li, Zhi-Gang Zeng, Jian Zou, Tian-Ning Jiang, Jun Song, Zhang-Jun Liu, Qi-Lun Ren, Guo-Sheng Publication details: Translational oncology Aug 2018 In: Translational oncology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	25.	Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study. [electronic resource] by Xie, Jie Cao, Jun Wang, Jing-Fen Zhang, Bai-Hong Zeng, Xiao-Hua Zheng, Hong Zhang, Yang Cai, Li Wu, Yu-Dong Yao, Qiang Zhao, Xiao-Chun Mao, Wei-Dong Jiang, Ai-Mei Chen, Shao-Shui Yang, Shun-E Wang, Shu-Sen Wang, Jian-Hong Pan, Yue-Yin Ren, Bi-Yong Chen, Yan-Ju Ouyang, Li-Zhi Lei, Kai-Jian Gao, Jing-Hua Huang, Wen-He Huang, Zhan Shou, Tao He, Yan-Ling Cheng, Jing Sun, Yang Li, Wei-Ming Cui, Shu-de Wang, Xin Rao, Zhi-Guo Ma, Hu Liu, Wei Wu, Xue-Yong Shen, Wei-Xi Cao, Fei-Lin Xiao, Ze-Min Wu, Biao Tian, Shu-Yan Meng, Dong Shen, Peng Wang, Bi-Yun Wang, Zhonghua Zhang, Jian Wang, Leiping Hu, Xi-Chun Producer: 20190319 In: Breast cancer research and treatment vol. 168 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)